Inhibition of Nox2 Oxidase Activity Ameliorates Influenza A Virus-Induced Lung Inflammation

English version České info

Influenza A virus pandemics and emerging anti-viral resistance highlight the urgent need for novel generic pharmacological strategies that reduce both viral replication and lung inflammation. We investigated whether the primary enzymatic source of inflammatory cell ROS (reactive oxygen species), Nox2-containing NADPH oxidase, is a novel pharmacological target against the lung inflammation caused by influenza A viruses. Male WT (C57BL/6) and Nox2^−/y mice were infected intranasally with low pathogenicity (X-31, H3N2) or higher pathogenicity (PR8, H1N1) influenza A virus. Viral titer, airways inflammation, superoxide and peroxynitrite production, lung histopathology, pro-inflammatory (MCP-1) and antiviral (IL-1β) cytokines/chemokines, CD8⁺ T cell effector function and alveolar epithelial cell apoptosis were assessed. Infection of Nox2^−/y mice with X-31 virus resulted in a significant reduction in viral titers, BALF macrophages, peri-bronchial inflammation, BALF inflammatory cell superoxide and lung tissue peroxynitrite production, MCP-1 levels and alveolar epithelial cell apoptosis when compared to WT control mice. Lung levels of IL-1β were ∼3-fold higher in Nox2^−/y mice. The numbers of influenza-specific CD8+D^bNP₃₆₆+ and D^bPA₂₂₄+ T cells in the BALF and spleen were comparable in WT and Nox2^−/y mice. In vivo administration of the Nox2 inhibitor apocynin significantly suppressed viral titer, airways inflammation and inflammatory cell superoxide production following infection with X-31 or PR8. In conclusion, these findings indicate that Nox2 inhibitors have therapeutic potential for control of lung inflammation and damage in an influenza strain-independent manner.

Vyšlo v časopise: Inhibition of Nox2 Oxidase Activity Ameliorates Influenza A Virus-Induced Lung Inflammation. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001271
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001271

Souhrn

Zdroje

1. La GrutaNL

KedzierskaK

StambasJ

DohertyPC

2007 A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85 85 92

2. TumpeyTM

BaslerCF

AguilarPV

ZengH

SolorzanoA

2005 Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310 77 80

3. OdaT

AkaikeT

HamamotoT

SuzukiF

HiranoT

1989 Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244 974 976

4. ImaiY

KubaK

NeelyGG

Yaghubian-MalhamiR

PerkmannT

2008 Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133 235 249

5. SelemidisS

SobeyCG

WinglerK

SchmidtHH

DrummondGR

2008 NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 120 254 291

6. BedardK

KrauseKH

2007 The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87 245 313

7. SnelgroveRJ

EdwardsL

RaeAJ

HussellT

2006 An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol 36 1364 1373

8. WebbyR

AndreanskyS

StambasJ

RehgJ

WebsterR

2003 Protection and compensation in the influenza virus-specific CD8+ T cell response. Proc Natl Acad Sci USA 100 7235 7240

9. SzretterKJ

GangappaS

LuX

SmithC

ShiehWJ

2007 Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 81 2736 2744

10. SchmitzN

KurrerM

BachmannMF

KopfM

2005 Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 79 6441 6448

11. JacksonSH

DevadasS

KwonJ

PintoLA

WilliamsMS

2004 T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5 818 827

12. HeroldS

SteinmuellerM

von WulffenW

CakarovaL

PintoR

2008 Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 205 3065 3077

13. KobasaD

JonesSM

ShinyaK

KashJC

CoppsJ

2007 Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445 319 323

14. SzaboC

IschiropoulosH

RadiR

2007 Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6 662 680

15. AkaikeT

NoguchiY

IjiriS

SetoguchiK

SugaM

1996 Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci U S A 93 2448 2453

16. DessingMC

van der SluijsKF

FlorquinS

van der PollT

2007 Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia. Clin Immunol 125 328 336

17. MillerAA

DrummondGR

MastAE

SchmidtHH

SobeyCG

2007 Effect of Gender on NADPH-Oxidase Activity, Expression, and Function in the Cerebral Circulation. Stroke 38 2142 2149

18. CareyMA

BradburyJA

SeubertJM

LangenbachR

ZeldinDC

2005 Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. J Immunol 175 6878 6884

19. ZhengBJ

ChanKW

LinYP

ZhaoGY

ChanC

2008 Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci U S A 105 8091 8096

20. AkaikeT

MaedaH

2000 Nitric oxide and virus infection. Immunology 101 300 308

21. GeilerJ

MichaelisM

NaczkP

LeutzA

LangerK

2010 N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem Pharmacol 79 413 420

22. SavinaA

JancicC

HuguesS

GuermonprezP

VargasP

2006 NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126 205 218

23. JackmanKA

MillerAA

De SilvaTM

CrackPJ

DrummondGR

2009 Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice. Br J Pharmacol 156 680 688

24. MosconaA

2008 Medical management of influenza infection. Annu Rev Med 59 397 413

25. VlahosR

BozinovskiS

ChanSP

IvanovS

LindenA

2010 Neutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation. Am J Respir Crit Care Med 182 34 40

26. VlahosR

BozinovskiS

JonesJE

PowellJ

GrasJ

2006 Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 290 L931 945

27. TannockGA

PaulJA

BarryRD

1984 Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun 43 457 462

28. La GrutaNL

TurnerSJ

DohertyPC

2004 Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity. J Immunol 172 5553 5560